Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Conceptus reports first quarter financial results.


SAN CARLOS San Carlos (săn kär`lōs), residential city (1990 pop. 26,167), San Mateo co., W Calif.; inc. 1925. The chief manufactures are plastic products, hardware, and machine parts. , Calif.--(BUSINESS WIRE)--April 23, 1996--Conceptus, Inc. (Nasdaq: CPTS CPTS Certified Penetration Testing Specialist (network security)
CPTS Comptroller Squadron
CPTS Computer Program Test Specifications
CPTS Catastrophe Personnel Tracking System
CPTS Claims Procedure Training Specialist
) today announced the financial results for its first quarter of fiscal year 1996, the three-month period ended March 31, 1996. The Company reported net loss of $1,465,000, or a $0.19 supplemental loss per share, on revenues of $82,000. As of March 31, 1996, the Company had cash, cash equivalents, and short-term investments of $47.9 million.

In February 1996, the Company completed an initial public offering of 3.45 million shares of Common Stock, at $14.00 per share, which resulted in net proceeds Net Proceeds

The amount received after all costs are deducted from the sale of a piece of property or security.

Notes:
In the case of an investor selling a security, net proceeds represent the proceeds from the sale minus any trading costs (i.e. commissions).
 of the offering to the Company of approximately $44 million.

The Company's underwriters UBS UBS Union Bank of Switzerland
UBS United Bible Societies
UBS United Blood Services
UBS United Buying Service
UBS Used Bookstore
UBS University Business Services
UBS Universal Building Society (UK)
UBS Ulaanbaatar Broadcasting System
 Securities Inc. and Piper Jaffray Piper Jaffray & Co. (NYSE: PJC), often shortened to just Piper Jaffray or PiperJaffray, is a U.S. middle-market investment banking firm based in Minneapolis, Minnesota and is a focused on delivering financial advice, investment products and transaction execution  Inc., have decided to release early a portion of the shares that were subject to a 180 day lock-up in conjunction with the initial public offering. As of May 1, 1996, one-third of all common shares of Conceptus conceptus /con·cep·tus/ (-tus) the product of the union of oocyte and spermatozoon at any stage of development from fertilization until birth, including extraembryonic membranes as well as the embryo or fetus. , Inc. which were subject to the "lock-up" will be released from that lock-up provision. This will result in approximately 1.3 million shares of stock which will become immediately tradable in the public market. Some of these shares will be subject to certain restrictions upon resale.

Conceptus, Inc. designs, develops and markets innovative medical devices that provide minimally invasive access to the female reproductive system reproductive system, in animals, the anatomical organs concerned with production of offspring. In humans and other mammals the female reproductive system produces the female reproductive cells (the eggs, or ova) and contains an organ in which development of the fetus . The Company's initial focus is on the development of systems to improve the diagnosis and treatment of fallopian tube fallopian tube (fəlō`pēən), either of a pair of tubes extending from the uterus to the paired ovaries in the human female, also called oviducts, technically known as the uterine tube.  diseases and disorders, a primary cause of infertility. The Company is also developing a system to provide a non-surgical approach to fallopian tube sterilization sterilization

Any surgical procedure intended to end fertility permanently (see contraception). Such operations remove or interrupt the anatomical pathways through which the cells involved in fertilization travel (see reproductive system).
, the most commonly performed contraceptive procedure worldwide. -0-

                                CONCEPTUS, INC.
                           STATEMENTS OF OPERATIONS
                (In thousands of dollars, except per share data)
                                  (unaudited)




                                   For the quarter ended
                                          March 31
                                       1996     1995


Total revenue                        $   82  $    99
Gross margin                            (77)    (193)
Operating expense                     1,780    1,060
Other income, net                       392       45
Net loss                            $(1,465) $(1,208)
Supplemental loss per share(a)      $ (0.19) $ (0.33)
Supplemental weighted average
   common shares outstanding(a)       7,638    3,678




Condensed Balance Sheet


                                     3/31/96  3/31/95


Cash, cash equivalents and
   short-term investments           $ 47,947  $ 4,028
Total assets                        $ 48,765  $ 4,996
Total liabilities                   $  1,398  $   843


Redeemable convertible
 preferred stock                    $     --  $11,453


Stockholders' equity
   (net capital deficiency)         $ 47,367  $(7,302)


(a) All shares and per share data reflect a one-for-three reverse
    stock split of the Company's common and preferred stock effected on
    November 29, 1995.


CONTACT: Sanford Fitch

Chief Financial Officer

Conceptus, Inc.

(415) 802-7240
COPYRIGHT 1996 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1996, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Apr 23, 1996
Words:419
Previous Article:WALDEN RESIDENTIAL PROPERTIES COMPLETES 1.8 MILLION SHARE PREFERRED STOCK OFFERING.
Next Article:PROGINET CREATES INTERNET DIVISION, EXPANDS MANAGEMENT TEAM.
Topics:



Related Articles
CONCEPTUS REPORTS SECOND QUARTER AND SIX MONTHS FINANCIAL RESULTS.
Conceptus reports third quarter 1996 financial results.
Conceptus Reports Fourth Quarter and Year 1996 Financial Results.
Conceptus Reports First Quarter 1997 Financial and Operational Results.
Conceptus Reports Third Quarter 1997 Financial and Operational Results.
Conceptus Reports Second Quarter 1998 Financial and Operational Results.
Conceptus Announces Organizational Changes and Successful Phase II Study/planned International Pivotal Trial of Stop Non-surgical Permanent...
Conceptus Reports First Quarter Results; Strengthens Executive Team in Preparation for Commencement of Pivotal Trial and International Marketing.
FDA CLEARS NESS HANDMASTER FOR US STROKE-VICTIM MARKET.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles